DPP4 and cancer: Whereas other proteases involved in cancer development and progression are mainly degrading ECM proteins, the DPP4 enzymatic activity of CD26 shows a different character, modulating the biological activity of many regulatory peptides and, at least, participating in systemic homeostasis.